Bcgepha

Live BCG Bacilli (Bacillus Calmette-Guerin), Brazilian Moreau Substrain, is a specialized medication used for intravesical administration. It is primarily employed in the treatment of certain bladder conditions, offering targeted therapeutic benefits.

Live BCG Bacilli is commonly used for intravesical therapy, particularly in the management of bladder cancer. This medication works by stimulating the immune system to target and destroy cancer cells within the bladder. It is often prescribed for patients who have undergone surgery for bladder cancer to reduce the risk of recurrence. The primary use of BCG is to prevent the recurrence of non-muscle-invasive bladder cancer.

When administered intravesically, Live BCG Bacilli can cause localized immune responses, which may lead to symptoms such as bladder irritation, frequency, and discomfort. Some individuals may experience flu-like symptoms, including fever, chills, and fatigue, as part of the body's immune reaction. These effects are generally temporary and subside as the treatment progresses.

Live BCG Bacilli should be handled with care to avoid contamination. It is important to follow the prescribed administration protocol to minimize the risk of infection or adverse reactions. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment. Proper hygiene practices are essential to prevent the spread of the bacilli to other parts of the body or to other individuals.

Live BCG Bacilli may interact with certain medications that suppress the immune system, such as corticosteroids or immunosuppressive drugs. Alcohol and other substances that weaken the immune response should be avoided during treatment. It is advisable to consult a healthcare provider regarding potential interactions with other medications or supplements.